Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,617.20
(
0.51%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
108.27
(
0.01%
)
Bitcoin
67,463.65
(
2.28%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: biomaven0 post# 143774

Thursday, 06/14/2012 8:44:47 AM

Thursday, June 14, 2012 8:44:47 AM

Post# of 257302
Agree that long term Eylea/Fovista should work just as well but if Roche or Novartis buy Ophthotech they can coformulate Fovista&Lucentis and have a unique new product.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today